SCHEMBL7225284

SCHEMBL7225284

CCN(CC)CC(=O)c1cc(C(=O)c2cccnc2)n(C)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 1/20 0.41
ALDH1A1 P00352 6/20 0.39
KDM4E B2RXH2 2/20 0.39
LMNA P02545 2/20 0.39
MAPT P10636 2/20 0.39
AGTR1 P30556 1/20 0.39
NPSR1 Q6W5P4 4/20 0.39
GFER P55789 2/20 0.39
PLOD2 O00469 2/20 0.38
L3MBTL1 Q9Y468 2/20 0.37
CYP2C19 P33261 2/20 0.37
MAPK1 P28482 1/20 0.37
APP P05067 1/20 0.36
GAA P10253 1/20 0.36
HCAR3 P49019 1/20 0.36
HCAR2 Q8TDS4 1/20 0.36
NAMPT P43490 1/20 0.36
F7 P08709 1/20 0.35
F3 P13726 1/20 0.35
SARM1 Q6SZW1 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7225639 0.78 ALDH1A1 (0.46) ALDH1A1KDM4ELMNAMAPTAGTR1
SCHEMBL5220805 0.75 ATM (0.50) HTTALDH1A1LMNAMAPTMAPK1
Hydrochloric Acid SCHEMBL5219306 0.74 ATM (0.49) HTTALDH1A1LMNAMAPTMAPK1
Hydrochloric Acid SCHEMBL5307392 0.73 HTT (0.45) HTTALDH1A1LMNAMAPTNPSR1
SCHEMBL15646421 0.71 ALDH1A1 (0.49) HTTALDH1A1KDM4ELMNAMAPT
SCHEMBL18228619 0.69 ALDH1A1 (0.49) ALDH1A1LMNAPLOD2APPGAA
SCHEMBL5219619 0.69 ALDH1A1 (0.49) ALDH1A1LMNAPLOD2MAPK1APP
SCHEMBL7224907 0.68 HPGD (0.42) HTTALDH1A1KDM4ELMNAMAPT
SCHEMBL7232690 0.68 ACHE (0.43) ALDH1A1KDM4ELMNAMAPTAGTR1
Niacin SCHEMBL11124237 0.68 ALDH1A1 (0.72) HTTALDH1A1KDM4ELMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2002002521-A2 AROYL AMINOACYL PYRROLE COMPOUNDS AND THEIR PHARMACEUTICAL USE ORTHO-MCNEIL PHARMACEUTICAL, INC. (US) 2002-01-10 WO claimed
US-6573267-B2 Central nervous system disorders ORTHO-MCNEIL PHARMACEUTICAL, INC. 2003-06-03 US disclosed
US-20020019436-A1 Useful aroyl aminoacyl pyrrole compounds ORTHO-MCNEIL PHARMACEUTICAL, INC. 2002-02-14 US disclosed
WO-2002002521-A2 AROYL AMINOACYL PYRROLE COMPOUNDS AND THEIR PHARMACEUTICAL USE ORTHO-MCNEIL PHARMACEUTICAL, INC. (US) 2002-01-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020019436-A1 Useful aroyl aminoacyl pyrrole compounds ABAT, GAP43, AADAT HTT 1977/4885ALDH1A1 1563/4885KDM4E 446/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.